AstraZeneca's COVID-19 vaccine is being withdrawn from the market in all countries.
Not just in Europe, where the withdrawal began on Tuesday, but all over the world.
The Telegraph reports that, according to the company, this decision is purely commercial.
Robert Mendick,
AstraZeneca explained that this anti-COVID vaccine, which is no longer manufactured or supplied, has already been replaced by updated vaccines that combat new variants. There is no longer as much demand for the Vaxzevria vaccine.
It should be noted that the company itself requested the withdrawal of the Vaxzevria vaccine, which had been circulating in the European Union since January 2021.
However, there may be another context for this withdrawal.
Just three months ago, AstraZeneca admitted in court documents that the vaccine can cause a very rare side effect: it causes blood clots and a decrease in blood platelets in the person taking the vaccine.
At issue is Thrombosis Thrombocytopenia Syndrome (TTS), which has an incidence of only 0.5 to 6.8 cases per 100,000 people vaccinated.
There have been lawsuits against the company over this apparent side effect.
In Portugal, for example, the administration of Vaxzevria was even discontinued after reports of the formation of various types of blood clots and lower efficacy rates against COVID-19.
"We are extremely proud of the role Vaxzevria has played in ending the global pandemic," says AstraZeneca.
There have been lawsuits against the company over this apparent side effect.
In Portugal, for example, the administration of Vaxzevria was even discontinued after reports of the formation of various types of blood clots and lower efficacy rates against COVID-19.
"We are extremely proud of the role Vaxzevria has played in ending the global pandemic," says AstraZeneca.
